Baker Hughes (BKR) is accelerating its pivot beyond traditional oil and gas, securing key roles in a landmark U.S. clean ammonia plant and expanding its stake in long-duration energy storage technology through a deepened partnership with Hydrostor.
Elevra Lithium (ASX:ELV) shares have tumbled over 30% in a week, abruptly reversing a stellar year-long rally. With no clear catalyst, investors are left weighing whether the pullback presents a buying window or signals deeper concerns in the lithium sector.
Summit Therapeutics (SMMT) finds itself at a crossroads, with its stock down over 30% in the past year. Conflicting signals from valuation models paint a complex picture: is the biotech firm dramatically overvalued on traditional metrics, or deeply undervalued based on future cash flows?
A dominant institutional ownership stake in Resources Connection, Inc. (NASDAQ:RGP) underscores significant outside influence over the professional services firm's direction, while also highlighting concentrated risk and governance dynamics.
Ethereum enters February 2026 under pressure, testing key support near $2,690 after a historically weak January. Analysts are divided on whether seasonal trends or shifting on-chain dynamics will dictate the month's direction.
Swiss watch and jewelry giant Swatch Group reported a steep decline in full-year profit and revenue, with pre-tax earnings nearly halved as consumer demand softened and operational costs climbed.
As Peloton Interactive prepares to report its Q2 fiscal 2026 results, investors are scrutinizing whether the fitness company's aggressive cost-cutting can finally fuel a sustainable turnaround, despite shares languishing 96% below their peak.
While regional tensions and market volatility capture headlines, a closer look reveals resilient companies with strong fundamentals. Driven by robust earnings and strategic positioning, select stocks in sectors from renewable energy to infrastructure present compelling cases for value-oriented investors navigating the complex landscape of early 2026.
The French government has intervened to halt the sale of Eutelsat's ground antenna network, labeling the satellite operator a strategic national asset crucial for both civilian and military communications in the face of growing competition from SpaceX's Starlink.
Oil prices pulled back from multi-month highs on Friday amid broad market risk aversion, yet President Trump's intensified focus on Iran continues to inject a significant risk premium into the market, setting Brent crude for its strongest monthly gain in years.
Williams-Sonoma's shares have delivered impressive multi-year gains, but recent valuation metrics present a mixed picture. As the stock hovers around $205, we analyze whether the home goods retailer's price truly reflects its fundamentals or if investors are paying a premium for past performance.
Hubbell Incorporated's stock has surged over 11% in the past month, closing near $498 and prompting a fresh debate among analysts over whether its current price fully reflects future growth potential amidst industry headwinds.
Real Matters Inc. (TSE: REAL) kicked off its 2026 fiscal year with robust double-digit revenue growth and a return to profitability, defying typical seasonal headwinds. The company's performance was fueled by market share gains, new client launches, and improved operational efficiency across its U.S. and Canadian segments.
Bitcoin tumbled toward $81,000 as markets reacted to the potential nomination of former Fed Governor Kevin Warsh, whose history of monetary hawkishness is viewed as a headwind for risk assets like cryptocurrency.
Mitsubishi Corporation and U.S.-based Aethon Energy have announced a strategic global alliance aimed at co-developing projects across liquefied natural gas (LNG), carbon capture, geothermal energy, and digital infrastructure, marking a significant step in the Japanese conglomerate's lower-carbon expansion.
German industrial giant Thyssenkrupp is exploring the sale of a significant minority stake in its Rothe Erde bearings division, a move analysts say could signal a broader portfolio reshuffle and highlight persistent valuation gaps within the conglomerate.
The medical technology giant reported double-digit organic sales growth and robust profitability for 2025, driven by record installations of its Mako surgical robots. While projecting continued strength for 2026, management acknowledged incremental tariff pressures but expressed confidence in the company's ability to sustain margin expansion.
Despite a mixed analyst outlook, Morgan Stanley projects robust growth for Full Truck Alliance's core commission business, even as overall revenue faces headwinds. The digital freight platform's long-term strategy is gaining favor.
H.C. Wainwright has trimmed its price target on Genmab following mixed Phase 3 results for its lymphoma drug EPKINLY, though maintains a Buy rating, citing precedent and ongoing trials.
Citizens reiterates a 'Market Outperform' rating and $396 price target for BeOne Medicines (ONC), driven by robust Phase 3 trial results in gastric cancer. The firm highlights the company's strong pipeline and cash position as key growth drivers.
